// App-Quantinova.ai

O06 : Hydroxychloroquine use, risk of retinal toxicity, and potential impact of screening in a large tertiary centre

Researchers

Presenter

  • Mark Yates

Principal Investigators

  • Katie Bechman

  • Sujith Subesinghe

  • Andrew Rutherford

  • Mark Russell

  • Ritu Malaiya

  • John Stack

  • James Galloway

Medical Centers

  • Academic Department of Rheumatology, King's College London, London, UNITED KINGDOM

  • Rheumatology Department, King s College Hospital, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic retinopathy

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved